CorVent Medical

CorVent Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $27M

Overview

CorVent Medical is a private, commercial-stage medical device company targeting the respiratory support market with its ICU-standard RESPOND® ventilator. The company's value proposition centers on a streamlined, durable design that eliminates traditional service contracts, offers a 5-year warranty, and integrates connectivity for EHR and remote monitoring. It aims to address demand from acute, post-acute, and emergency stockpile settings by providing a cost-effective and easy-to-use alternative to complex, maintenance-heavy ventilators.

Respiratory

Technology Platform

ICU-standard mechanical ventilator platform (RESPOND®) designed for simplicity, durability, and connectivity. Features include invasive/non-invasive modes, pediatric-to-adult use, low-flow O2 source compatibility, integrated antiviral filters, remote monitoring (CorVision™), EHR integration, and a hot-swappable battery. Differentiated by a no-service-contract model and a standard 5-year warranty.

Funding History

2
Total raised:$27M
Series A$22M
Seed$5M

Opportunities

Significant demand in post-acute care settings (LTACHs, SNFs) and rural hospitals for capable, low-maintenance ventilators.
Government and institutional stockpiling for pandemic and emergency preparedness represents a large, strategic market.
The industry shift towards value-based care favors cost-saving solutions like CorVent's no-service-contract model.

Risk Factors

Facing intense competition from large, entrenched medtech companies with extensive service networks and brand loyalty.
The innovative no-service-contract business model sacrifices recurring revenue and places greater financial burden on manufacturing efficiency and volume sales.
As a new entrant, establishing clinical proof and trust in device reliability over the long term is critical and challenging.

Competitive Landscape

The ventilator market is dominated by multinational giants like Medtronic, Philips, Getinge, and Vyaire, which offer comprehensive portfolios and global service contracts. CorVent's competition also includes more agile players like Zoll Medical (awarded BARDA contracts) and other startups. CorVent's primary competitive angles are its simplified, low-total-cost-of-ownership model, U.S. manufacturing, and focus on ease of use for non-ICU settings.